Research

Communication and Advancement Awards Report Fiscal Year 2000
Medical Center Area
Medicine
Anesthesiology

Primary Total: $2.
 Collaborative Total: $7,589.

DANIEL WERMELING/MICHAEL DRASS
* A Single-Site, Phase II, Open Labeled, Rising Dose, Feasibility, Safety, and Efficey Study of SNX-111 Administered Intrathecally in Bolus Doses for Chronic Pain, (461749), Neurex, $4,268.00

PAUL SLOAN
* Open Label, Sequential Crossover Evaluation of the Analgesic Dose Equivalence, Efficacy and, (463452), Scirex, $3,315.00

PAUL SLOAN
A Multicenter, Open-Label, Extension Study to Evaluate the Long-Term Safety and Effectiveness of Numorphan cr in Patients with Chronic Pain, (463818), Scirex, $2.00

SCOTT HAMANN/GEORGE COLCLOUGH/JOSEPH HOLTMAN
* PCA Morphine with Maloxone in Patients with Pain Following Hysterectomy, (463422), Research Services Inc, $2.00

SCOTT HAMANN/JOSEPH HOLTMAN/WILLIAM WITT
* Antagonism of Opioid Excitaroy Receptor Function in the Intrathecal Management of Refract Chronic Pain, (463423), Pain Therapeutics Inc, $2.00


* Cross-referenced accounts where the project director/s are affiliated with more than one department, college or center
Information Systems
Questions:
 Deborah Davis,  Office of Sponsored Projects Administration, 112 Kinkead Hall, 0057, 257-8311

UK Awards Home    Research    University of Kentucky